Dror Rom, PhD
Chairman

Robert Babilon MS, MBA
Chief Operating Officer

Chip Rodden
Member

Dror Rom, PhD

President and Chief Executive Officer
Prosoft Clinical

Dr. Rom is a biostatistician with over 30 years of experience working in the pharmaceutical industry. Dr. Rom’s career has combined research and clinical data analyses. His research interests focus on statistical methodologies applicable to clinical trials, primarily in the areas of numerical computations, bioequivalence, multiple comparisons, and adaptive designs, which have led to numerous publications including the co-authoring of a SAS book on the subject of multiple comparisons.

Robert Babilon MS, MBA

Chief Operating Officer
Prosoft Clinical


Mr. Babilon has both an MBA from St. Joseph’s University and an MS in Microbiology and Immunology from Temple University, Mr. Babilon’s expertise lies in Regulatory Affairs, Quality Assurance, and Business Development. Over the course of his 30 years in the pharmaceutical industry he has provided numerous strategic product development plans, has supported international clinical development programs and has organized and submitted marketing applications leading to approvals for Dermatology, Analgesia, HIV, Oncology, Gastrointestinal, Neurology, and Cardio-Renal drug and device products. Additionally, Mr. Babilon has participated in numerous FDA Advisory Committee meetings and is an established presenter of US FDA Regulations, including for Medicademy, an international educational facility in Denmark.

Michael Nordsiek

Board Member

Mr. Nordsiek has over 30 years of experience in the pharmaceutical industry with specialization in CMC, manufacturing, formulation and overall product, package and process development, and validation and site transfers. Mr. Nordsiek obtained his BS in Pharmacy from the West Virginia University School of Pharmacy and has participated in or led the global development of products, teams and companies in the therapeutic areas of dermatology, women’s health, respiratory, and cardio-renal health. Mr. Nordsiek specializes in Regulatory Affairs, Project Management, and Quality and Business/Product Development. As a co-founder of several specialty pharmaceutical companies over the last decade, along with his partners, he has successfully secured the funding, products, and personnel necessary to build companies that achieved up to $400 million in yearly revenue.

Chip Rodden

Board Member

Mr. Rodden has been in the computer science field for over 35 years and has been involved in a variety of different specialties within that discipline. He has extensive knowledge in the optimization of software for super computers and microprocessors, and has taught classes in this subject around the world. He has partnered in starting a successful computer networking business as the lead software engineer.